Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Michel Binoux"'
Autor:
Ariane Berdal, Yves Le Bouc, Michel Binoux, Sylvie Babajko, Nadia Ben Lagha, Pierrette Menuelle, Danielle Seurin
Publikováno v:
Endocrinology. 147:4730-4737
In humans, intrauterine growth retardation is correlated to high levels of serum IGF binding protein-1 (IGFBP-1). This present study analyzes in vivo the impact of circulating IGFBP-1 on body growth associated to bone mineralization and carbohydrate
Autor:
Michel Binoux, Stéphanie Hembert, Claudine Pisselet, Christophe Staub, Danielle Seurin, Philippe Monget, Pascal Froment, Jon E. Levine, Bernadette Delaleu, M. Magistrini, Larry Johnson
Publikováno v:
Endocrinology
Endocrinology, Endocrine Society, 2004, 145 (4), pp.2080-2091
Endocrinology, Endocrine Society, 2004, 145 (4), pp.2080-2091
Adult transgenic mice overexpressing human insulin-like growth factor-binding protein-1 in the liver present reproductive abnormalities in both sexes. In the present work, we have investigated the mechanisms responsible for limiting breeding capacity
Publikováno v:
FEBS Letters. 527:293-297
Insulin-like growth factor binding protein-3, IGFBP-3, specifically binds to IGFs with high affinity, but it is also capable of modulating the IGF-I signalling pathway or inducing apoptosis independently of its binding to IGFs. The molecular mechanis
Autor:
Michel Binoux, Jean-Marc Ricort
Publikováno v:
Journal of Biological Chemistry. 277:19448-19454
The proliferative action of insulin-like growth factors (IGF-I and -II) is mediated via the type I IGF receptor (IGF-IR) and is modulated by their association with high affinity binding proteins, IGFBP-1 to -6. We recently found that, in addition to
Publikováno v:
Biochemical and Biophysical Research Communications. 293:55-60
In an earlier study, we reported that an N-terminal proteolytic fragment ((1-95)IGFBP-3) corresponding to the first 95 residues of human insulin-like growth factor binding protein-3 (IGFBP-3) inhibits proliferation in a variety of fibroblasts. With a
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:1942-1952
The ligand immunofunctional assay for plasma insulin-like growth factor (IGF) binding protein (IGFBP)-3 developed in our laboratory provides for specific measurement of intact, as opposed to proteolyzed, IGFBP-3. IGFBP-bound IGFs are dissociated and
Autor:
Michel Binoux, Claudine Lassarre
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:1260-1266
Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) is a fundamental mechanism in the regulation of IGF-I bioavailability in the bloodstream. Its measurement by Western immunoblotting provides only semiquantitative estimatio
Autor:
Jean-Marc Ricort, Michel Binoux
Publikováno v:
Endocrinology. 142:108-113
Insulin-like growth factor binding proteins (IGFBPs) regulate the cellular actions of the IGFs owing to their strong affinities, which are equal to or stronger than the affinity of the type 1 IGF receptor (IGF-IR), the mediator of IGF signal transduc
Publikováno v:
Growth Hormone & IGF Research. 10:267-274
Insulin-like growth factors (IGFs) produced in the brain are known to participate in brain development via activation of the type 1 IGF receptor. IGF binding proteins (IGFBPs) modulate the cellular action of IGFs and some are expressed in the fetal b
Autor:
Liliane J. Striker, Gary E. Striker, Danielle Seurin, Marie-Christine Verpont, Michel Binoux, Sophie Doublier, Bruno Fouqueray, Laurent Baud, Patrice Callard
Publikováno v:
Kidney International. 57(6):2299-2307
Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1. Background The growth hormone (GH)/insulin-like growth factor (IGF) system is thought to participate in the glomerulosclerosis process. Because IGF-binding